The heart is an organ with an unforgiving relationship to its blood supply. Cardiac muscle works continuously and demands a constant delivery of oxygen, which means the coronary vasculature must grow in careful proportion to the muscle it serves. Too little vessel growth starves the tissue; too much creates a disorganized, inefficient network. During development, and again after injury, the heart must therefore solve a problem that engineers would recognize immediately: building the right amount of blood vessel, and knowing precisely when to stop. The new study suggests that the zebrafish heart solves this problem with a dedicated cellular control system, one that had gone unnoticed until now because it only becomes prominent under specific conditions of growth and repair.

The research is rooted in a question that has animated the field for years. Zebrafish possess a remarkable ability that mammals largely lack: after significant injury to the heart, they can regenerate the damaged muscle almost completely, restoring function rather than forming a permanent scar. Understanding how they accomplish this has become a major strategy for identifying the regenerative programs that might, in principle, be reawakened in human patients. Dr. Jingli Cao, associate professor of cell and developmental biology at Weill Cornell Medicine and a member of its Cardiovascular Research Institute, has spent much of his career tracing this process. As a postdoctoral fellow at Duke University, he determined that the epicardium, the thin layer of cells that envelops the heart, provides both the signals and the cells needed to regenerate heart tissue in zebrafish.

The epicardium has long been viewed as more than passive packaging. In response to injury, it activates a specific population of progenitor cells that give rise to the various cell types involved in regenerating heart muscle and coronary blood vessels. But a deeper puzzle remained: what directs these precursor cells to specialize into one fate or another? To answer it, Dr. Cao’s team, including graduate student Björn Perder and postdoctoral fellow Dr. Yu Xia, catalogued the genes that switch on in these cells when the heart is injured. Among the activated genes they identified a master regulator called scxa, a transcription factor that steers a subset of epicardial progenitor cells toward a fate that had never been characterized before.

That fate turned out to be a novel perivascular cell type. Once specified by scxa, these cells migrate to the coronary vessels and surround them, taking up a position that immediately suggested a regulatory role. Perivascular cells in general are known to modulate vessel stability, maturation, and remodeling, so the location of the new cell type was a strong clue. The team found that these cells express a particular type of collagen, and that this collagen does more than provide structural support. The cells process the collagen molecule to release a small protein fragment, a derived signal that ultimately curbs further vessel expansion. In other words, the very cells that accompany the growing vasculature carry within them the molecular message that tells the network when enough is enough.

Dr. Cao framed the significance of this arrangement in practical terms. During development, or when the heart is damaged, the organism needs to build the right amount of blood vessel, and it needs to know when to stop, he noted. The newly discovered system provides that layer of control. This kind of negative feedback is a recurring theme in biology, but identifying the specific cell type and the specific signaling molecule responsible in the heart gives researchers a concrete handle on a process that has been difficult to study. It also suggests that disorders of vascular growth in the heart, whether insufficient vessel formation after injury or excessive, disorganized growth, might be traceable to failures of this regulatory circuit.

Perhaps the most intriguing aspect of the study is what it reveals about timing. The researchers had previously shown that when regions of the heart experience low oxygen levels, a condition known as hypoxia, signals from the epicardium coordinate the growth of heart muscle and coronary vessels so that the two develop in step with each other. The new findings illuminate a plausible mechanism for how this coordination happens. Low oxygen appears to act as an environmental cue that temporarily activates scxa, which in turn directs a subset of epicardial progenitors toward the perivascular fate. These cells then surround the coronary vessels and may help regulate their development and remodeling. Hypoxia, in this model, is not merely a stress signal but an instruction: it tells the epicardium that the tissue is outpacing its blood supply and that vascular support cells are needed now.

This oxygen-sensing logic has an elegant developmental rationale. As heart muscle proliferates, the growing tissue inevitably pushes local oxygen levels down, because diffusion cannot keep pace with expansion. By using hypoxia as the trigger for scxa activation, the heart ensures that vessel-supporting cells are generated exactly where and when the muscle is growing fastest. The same mechanism likely operates after injury, when the damaged tissue becomes hypoxic and the epicardium mounts its regenerative response. If the system works as the study suggests, the perivascular cells and their collagen-derived braking signal would form a self-correcting loop: hypoxia recruits the cells, the cells support vessel growth, and the vessels restore oxygen delivery, at which point the signal to expand fades.

The translational implications are considerable, though the researchers are careful about the distance between zebrafish and humans. Humans do carry a related gene, SCX, but no one yet knows whether human epicardial cells use it in the same way as their zebrafish counterparts. There is a cautionary wrinkle: after an injury such as a heart attack in mammals, SCX is switched on in cardiac fibroblasts, the cells that promote scar tissue formation. In mammals, then, the same regulatory gene appears to be associated with fibrosis rather than regeneration. Dr. Cao suggests that in the future it may be possible to use SCX to reactivate human epicardial cells and steer them toward generating the cells and signals that promote heart regeneration, redirecting the gene’s activity away from scarring and toward repair.

Toward that end, Dr. Cao’s laboratory is working with cultured human epicardial cells and cardiac organoids, laboratory-grown miniature tissue models, to develop ways of using activated cells to repair damaged regions of the heart. The vision is a kind of biological bandage: a living material that could be applied to an injured site and induce controlled growth of both heart muscle and vessels, rebuilding the tissue in a coordinated fashion rather than leaving a non-contractile scar. Dr. Cao is quick to temper expectations, noting that he does not believe a single magic factor controls regeneration. But, as he put it, the team has discovered one more factor, one more mechanism that could eventually contribute to turning on epicardial cells and repairing human hearts. The work was supported by the New York State Stem Cell Science program, the Louis and Rachel Rudin Foundation, the Belgian American Educational Foundation, the American Heart Association, and the National Institutes of Health, reflecting the broad institutional bet that the zebrafish heart still has many secrets worth stealing.

Subject of Research: Discovery of a novel scxa-specified perivascular cell type that regulates coronary vascular development in the regenerating zebrafish heart

Article Title: Newly discovered cell helps shape blood vessel growth in the heart

Article References: Newly discovered cell helps shape blood vessel growth in the heart. (n.d.). Original publication

Image Credits: AI Generated

DOI: Not provided

Keywords: zebrafish, heart regeneration, epicardium, perivascular cells, coronary vessels, scxa, hypoxia, collagen, Weill Cornell Medicine, Nature Communications, cardiac progenitor cells, vascular development

The study, titled “Multiple simulated spaceflight stressors impact cardiac fibrosis, calcium dynamics, immune function, cytokines and gene variants in rat, Rattus norvegicus,” examined how several simulated spaceflight stressors influenced the rodent heart across multiple biological domains. Rather than focusing on a single endpoint, the investigators assessed structural changes in cardiac tissue, calcium handling within heart cells, immune function, circulating cytokine profiles and gene variants. This breadth matters because the cardiovascular system is integrated: a shift in immune signaling or calcium dynamics can ripple outward into tissue remodeling, electrical instability and impaired pumping function over time.

Galactic cosmic radiation is one of the defining hazards of missions beyond the protective envelope of Earth’s magnetosphere. Unlike the charged particles trapped in the Van Allen belts or the sporadic bursts of solar particle events, galactic cosmic rays consist largely of high-energy protons and heavier atomic nuclei traveling at near-relativistic speeds. When these particles, sometimes called HZE ions, pass through biological tissue, they deposit dense tracks of ionization that can damage DNA, proteins and cell membranes in ways that differ from the sparse ionizations produced by X-rays or gamma rays. Because Earth’s magnetic field and atmosphere shield people on the ground and largely protect crews in low Earth orbit, this radiation environment is essentially impossible to study directly in humans without leaving the planet.

To approximate that environment on the ground, researchers use particle accelerators to deliver carefully calibrated doses of heavy ions and protons to animal models. In the rat study, exposure to this simulated galactic cosmic radiation was associated with the accumulation of collagen in and around the coronary vessel wall. Collagen is the structural protein that forms scar tissue, and its excessive deposition, known as fibrosis, stiffens tissue and interferes with normal function. Perivascular fibrosis, specifically, thickens the supporting structures around blood vessels, which can restrict the ability of coronary vessels to dilate and deliver blood on demand. In the heart, such changes are associated with reduced compliance and an elevated risk of diastolic dysfunction in clinical medicine.

What makes the result particularly noteworthy is its timing. The fibrotic changes emerged during long-term follow-up, meaning the hearts of the exposed animals did not show the full extent of remodeling immediately after the radiation exposure. This delayed pattern is consistent with a broader theme in radiation biology: some forms of injury unfold slowly as cells respond to initial damage, inflammatory signals persist, and tissue repair processes go awry. For mission planners and flight surgeons, delayed effects are the most difficult kind to manage, because they may not announce themselves during a mission or even in the years immediately following it.

The study’s multi-domain design also reflects how modern space biology frames health risk. Calcium dynamics within cardiac cells are central to every heartbeat: calcium ions trigger the contraction of the heart muscle and must be rapidly cleared to allow relaxation. Disruption of this cycling can impair both the strength and rhythm of the heartbeat. Immune function and cytokines, the signaling molecules that coordinate inflammatory responses, connect to cardiac health because chronic low-grade inflammation is a recognized driver of fibrosis and vascular disease. By measuring these systems alongside structural tissue changes and genetic variation among the animals, the researchers could build a more complete picture of how simulated spaceflight stressors propagate through biology.

The inclusion of gene variants in the analysis acknowledges an important reality of radiation risk: individual susceptibility is not uniform. Variation in genes governing DNA repair, antioxidant defenses, inflammatory signaling and calcium handling could plausibly influence how strongly a given organism responds to the same radiation exposure. In a population of rats, as in a population of astronauts, some individuals may be intrinsically more vulnerable to fibrotic remodeling or immune dysregulation than others. Understanding that variability is a prerequisite for personalized risk assessment, which agencies such as NASA have identified as a priority for protecting crews on long-duration missions.

The research was supported by funding from the National Aeronautics and Space Administration under award 80NSSC19K0498 and by the Foundation for Heart Science under award 081735, with the funders having no role in study design, data collection, analysis or manuscript preparation. The authors declared no competing interests. The work was conducted by researchers based in the United States and published as a peer-reviewed article in PLOS One under the DOI 10.1371/journal.pone.0357485. An accompanying illustration by Dave Kiehl, released under a CC-BY 4.0 license, depicts the potential cardiovascular effects of galactic cosmic radiation during a Mars mission, including the perivascular fibrosis observed in the study.

The relevance to human spaceflight is direct. A crewed mission to Mars would expose astronauts to months of galactic cosmic radiation with no option for early return, and current mitigation strategies, primarily spacecraft shielding and mission duration limits, offer only partial protection against high-energy heavy ions. Cardiac fibrosis is a slow, cumulative process in terrestrial medicine, linked over decades to hypertension, aging and cancer therapies involving radiation to the chest. If deep-space radiation accelerates or initiates similar remodeling, the cardiovascular consequences might only surface years after a mission concludes, complicating both health monitoring and long-term care of former astronauts.

At the same time, the researchers and the field at large caution against overinterpreting a single animal study. Rats are not humans, simulated radiation exposures involve dose rates and particle spectra that only approximate the true space environment, and the doses used in laboratory studies are often delivered over compressed timeframes compared with the chronic, low-dose exposure of an actual mission. Translating these findings into human risk estimates requires replication across species, dose ranges and exposure schedules, as well as mechanistic work to identify the biological pathways linking heavy-ion exposure to collagen deposition in coronary vessels. Still, the study strengthens the case that the heart belongs on the list of organs that space agencies must actively monitor and protect, and it underscores a sobering possibility: the most consequential injuries of a journey to Mars may be the ones that reveal themselves only after the homecoming.

Subject of Research: Cardiac effects of simulated galactic cosmic radiation exposure in rats

Article Title: Simulated space radiation may damage rat hearts long after exposure

Article References: Simulated space radiation may damage rat hearts long after exposure. (n.d.). Original publication

Image Credits: AI Generated

DOI: Not provided

Keywords: space radiation, galactic cosmic rays, cardiac fibrosis, rats, PLOS One, NASA, Mars missions, coronary vessels, collagen deposition, calcium dynamics, immune function, astronaut health